70P Overall survival of eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastatic breast cancer: A phase II, single-arm clinical trial.

Subjects

Subjects :

*METASTATIC breast cancer
*HER2 positive breast cancer
*OVERALL survival
*HORMONE receptor positive breast cancer
*TRASTUZUMAB
*ERIBULIN

Details

Language :

English

ISSN :

09237534

Volume :

34

Database :

Academic Search Index

Journal :

Annals of Oncology

Publication Type :

Academic Journal

Accession number :

173758087

Full Text :

https://doi.org/10.1016/j.annonc.2023.10.204